Find information about and book an appointment with Luciane Tsukamoto Kagohara, PhD ... Luciane Tsukamoto Kagohara, PhD. Johns Hopkins Affiliations: Johns Hopkins School of Medicine Faculty. Languages. English. Gender. Female. About. Primary Academic Title. Assistant Professor of Oncology ...
Luciane Tsukamoto Kagohara. Johns Hopkins University. Verified email at jhmi.edu. cancerimmunologyepigeneticsimmunotherapysingle cell sequencing. Articles ... T Lopatina, E Favaro, L Danilova, EJ Fertig, AV Favorov, LT Kagohara, ... Frontiers in Cell and Developmental Biology 8, 698, 2020. 23, 2020. KRAS mutation ...
Luciane Tsukamoto Kagohara. Assistant Professor. School of Medicine. 2011Research output 2011: 1Research output 2013: 1Research output 2014: 3Research ... CD4 T cell–activating neoantigens enhance personalized cancer vaccine efficacy. Huff, A. L., Longway, G., Mitchell, J. T., Andaloori, L., Davis-Marcisak, E ...
Dr. Luciane Kaghara is an Assistant Professor at Johns Hopkins Medicine. Her lab has a hybrid focus on understanding mechanisms of resistance to cancer therapies. Currently, her research applies high dimensional technologies, such as scRNA-seq and spatial transcriptomics, to examine intrinsic mechanisms of ...
Affiliation: Johns Hopkins University
Research interests: Cancer, Immunology, Epigenetics, and more
Assistant Professor at Johns Hopkins Medicine · Molecular and computational biologist hybrid. Currently investigating mechanisms of resistance to immunotherapies in hepatocellular carcinomas and pancreatic cancers using high dimensional single-cell (single-cell RNA-seq) and spatial transcriptomics technologies.
Luciane T. Kagohara's 65 research works with 318 citations and 5458 reads, including: Integration of Clinical Trial Spatial Multi-omics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery.
Sep 18, 2023 · ... Luciane T Kagohara. Affiliations. 1 Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 2 ... Research Support, Non-U.S. Gov't. MeSH terms. Carcinoma, Hepatocellular* / drug therapy; Carcinoma, Hepatocellular* / genetics; Humans; Liver ...